title: Managing a Rivaroxaban Bleed: Understanding the Difficulties in Acute Reversal of the New Oral Anticoagulants through a Case Report.
abstract: With the arrival of a new generation of oral anticoagulants significant burdens associated with warfarin's use on both the patient and the healthcare system have been alleviated. Nevertheless, a shortfall exists in regard to an agent or protocol for reversal of these new anticoagulants in the setting of an acute bleed. Our case of a patient presenting to the hospital with a vaginal bleed while on rivaroxaban highlights the difficulty in management without a clear protocol or agent for reversal of anticoagulation.
authors.affiliation: Department of Internal Medicine, Detroit Receiving Hospital/University Health Center, Suite 2E, 4201 St. Antoine Street, Detroit, MI 48201, USA.
authors.forename: Naveen
authors.identifier: 0000-0003-0477-6036
authors.initials: N
authors.lastname: Nannapaneni
authors.affiliation: Department of Internal Medicine, Detroit Receiving Hospital/University Health Center, Suite 2E, 4201 St. Antoine Street, Detroit, MI 48201, USA.
authors.forename: Robby
authors.initials: R
authors.lastname: Singh
authors.affiliation: Pharmacy Department, Detroit Medical Center, Detroit, MI, USA.
authors.forename: Paulina
authors.initials: P
authors.lastname: Mckay
authors.affiliation: Department of Internal Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
authors.forename: Marwan
authors.identifier: 0000-0001-5486-8057
authors.initials: M
authors.lastname: Al-Hajeili